| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Oct 2, 2025 | Oct 6, 2025 | NeueHealth, Inc. | Director | Sell | 27.5 | -2,005,192 | -36.51% | ✗ | $6.2K |
| Jun 21, 2022 | Jun 23, 2022 | Arcellx, Inc. | 10% Owner | Buy | 93.8 | +312,500 | 4.86% | ✗ | $5M |
| May 26, 2022 | May 31, 2022 | IonQ, Inc. | 10% Owner | Sell | 15.0 | -2,922,966 | -10.00% | ✗ | $17.1M |
| Feb 8, 2022 | Feb 9, 2022 | Arcellx, Inc. | 10% Owner | Buy | 100.0 | +1,583,333 | 32.65% | ✗ | $23.7M |
| Apr 13, 2021 | Apr 15, 2021 | OnKure Therapeutics, Inc. | 10% Owner | Buy | 100.0 | +666,666 | 16.19% | ✗ | $10M |
| Jul 14, 2020 | Jul 16, 2020 | Nkarta, Inc. | 10% Owner | Buy | 100.0 | +666,666 | 29.82% | ✗ | $12M |
| Feb 26, 2018 | Feb 27, 2018 | Oruka Therapeutics, Inc. | 10% Owner | Sell | 20.0 | -1,460,209 | -100.00% | ✗ | $731.3K |
| Jul 18, 2016 | Jul 20, 2016 | ARDELYX, INC. | 10% Owner | Buy | 100.0 | +1,527,301 | 40.15% | ✗ | $13.3M |
| Jan 13, 2016 | Jan 14, 2016 | ARDELYX, INC. | 10% Owner | Buy | 100.0 | +1,000,000 | 35.67% | ✗ | $10M |